Neurofibromatosis

LUCIUS Pharmaceutical announces the approval LuciMird in Laos

Vientiane, Laos - June 9, 2026 -Lucius Pharmaceutical is focused on providing effective, safe, and reliable medications and services for patients all over the world., today announced LuciMird (Mirdametinib) have been approved by the Ministry of Health of Laos. Mirdametinib is a medication used for the treatment of people with…